lateinischsepticus

Lateinischsepticus is a term used in medical literature to describe a specific type of septic shock that is associated with the use of certain antibiotics, particularly those containing the beta-lactam antibiotic ceftriaxone. The term was first identified in a case series published in 2007, where patients who received ceftriaxone developed a severe, life-threatening reaction characterized by hypotension, organ failure, and a specific pattern of laboratory abnormalities.

The mechanism behind lateinischsepticus is not fully understood, but it is believed to be related to the immune response to the antibiotic. Ceftriaxone is a broad-spectrum antibiotic that can cross-react with host tissues, leading to the production of antibodies that attack not only the targeted bacteria but also healthy tissues. This cross-reaction can trigger a systemic inflammatory response, resulting in the clinical features of septic shock.

The term "lateinischsepticus" is derived from the Latin word "septicus," which means "relating to blood poisoning," and the German word "lateinisch," which refers to the Latin origin of the antibiotic ceftriaxone. The condition is also known as ceftriaxone-induced anaphylactoid reaction or ceftriaxone-induced acute kidney injury.

The diagnosis of lateinischsepticus is clinical, based on the presence of septic shock and the recent administration of ceftriaxone. Laboratory tests may show elevated liver enzymes, kidney injury, and a specific pattern of autoantibodies. Treatment typically involves discontinuation of ceftriaxone and supportive care, including fluid resuscitation, vasopressors, and renal replacement therapy if necessary.

Lateinischsepticus is a rare but serious complication of ceftriaxone use, and awareness of this condition is important for healthcare providers to ensure appropriate antibiotic selection and monitoring of patients receiving ceftriaxone.